1370261-50-9

1370261-50-9 structure

Name: Anatumomab mafenatox
Chemical Name: Anatumomab mafenatox
CAS Number: 1370261-50-9
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2023-03-10 13:27:45
Modify Date: 2024-04-03 15:09:50
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1].

Name	Anatumomab mafenatox

Description	Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
Target	5T4[1]
References	[1]. Shaw DM, et al. A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma. Br J Cancer. 2007 Feb 26;96(4):567-74.

No Any Chemical & Physical Properties